X0306 4 2016-02-08 false 0001597553 Sage Therapeutics, Inc. SAGE 0001612861 Robichaud Albert C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 false true false false Chief Scientific Officer Stock Option (Right to Buy) 28.63 2016-02-08 4 A false 25000.00 0.00 A 2026-02-08 Common Stock 25000.00 25000.00 D The securities awarded on 2/08/2016 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 6,250 shares of common stock shall vest on the one year anniversary of the Vesting Start Date with 18,750 shares vesting in 36 equal monthly installments thereafter. Chief Scientific Officer /s/ Erin Lanciani, as Attorney-in-Fact for Albert Robichaud 2016-02-10